Adjuvant and neoadjuvant treatment for melanoma: integrating immunotherapy, radiation and systemic therapies into surgical practice
{{output}}
Systemic therapies have transformed melanoma care, delivering durable responses and survival benefits in metastatic and resected high-risk disease. Immune checkpoint inhibitors-particularly anti-programmed death 1 agents-have replaced interferon-based regimens... ...
